Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Rite Aid Posts Surprise Q3 Profit

By Eric Volkman - Dec 17, 2020 at 4:58PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The coronavirus didn't exactly have a damaging effect on the pharmacy chain.

Rite Aid ( RAD 2.33% ) did its shareholders right on Thursday by delivering a far-better-than-expected third quarter of fiscal 2021.

The big pharmacy operator published the results of the quarter this morning, and they revealed a 12% year-over-year jump in revenue to $6.1 billion. More encouragingly, against expectations, Rite Aid landed in the black on the bottom line, even as its adjusted net profit fell by 26% to $21.6 million, or $0.40 per share.

A Rite Aid store at twilight.

Image source: Rite Aid.

On average, analysts following the stock had been estimating the company would book $5.8 billion in revenue, and an adjusted net loss of $0.05 per share.

A big reason for Rite Aid's positive surprise was the cornavirus pandemic. With worries about health foremost on many customers' minds, pharmacy sales rose by over 6%. By comparison, front-end (i.e., nonpharmacy) sales crept up only by 0.3%. Meanwhile, the company's pharmacy benefits manager Elixir saw its take increase by a very robust 29% to $2.1 billion for the quarter.

Buoyed by these results, Rite Aid slightly increased its guidance for the full 2021 fiscal year. The company now believes its total revenue will land between $23.9 billion and $24.2 billion, which at the low end would mean a year-over-year improvement of almost 9% (previous guidance: $23.5 billion to $24 billion). Per share adjusted net income should be $0.45 to $0.85, and free cash flow is estimated at $50 million to $100 million.

With a mass rollout of coronavirus vaccines in the cards, Rite Aid has good momentum going into 2021. Investors rewarded this by bidding the stock up by over 17% on Thursday, trouncing the modest gain of the S&P 500 index on the day.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$12.32 (2.33%) $0.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
673%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.